A study by New York State Researchers state that Two doses of Pfizer Inc (PFE.N) and BioNTech COVID-19 vaccine has quickly lost most of its ability to prevent infection in children aged 5 to 11 unlike it was during the recent Omicron variant surge. According to
Kenya has received the second batch of 210,000 doses of Pfizer COVID-19 vaccines from the United States, boosting the country’s effort to inoculate its population against the pandemic. The vaccines arrived at the Jomo Kenyatta International Airport (JKIA) around 1 am on Tuesday from the COVAX facility. It is an
Pfizer and BioNTech said on Monday their COVID-19 vaccine is safe and effective for children aged 5 to 11. The companies said the vaccine induced a robust immune response in 5 to 11 year olds, and added that they planned to ask for authorization to use the vaccine in
Kenya is set to receive the first consignment of Pfizer COVID-19 vaccines this Friday. Health Cabinet Secretary Mutahi Kagwe together with the United States Ambassador to Kenya Eric W. Kneedler will receive the consignment at the Jomo Kenyatta International Airport (JKIA), at 2:00 pm. Kenya will also receive first consignment
